influenza
Conditions
Interventions
Control group:placebo
Experimental group:Jingyin solid table granules
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age of 18-65 years old male or female; (2) patients with body temperature =38? one or more respiratory symptoms (cough runny nose sore throat) and one or more systemic symptoms (fatigue headache myalgia) within 36 hours before enrollment; Patients with the above clinical manifestations of influenza and positive results of one or more of the following etiological tests: (1) positive for influenza virus nucleic acid test (2) positive for influenza antigen test (3) positive for influenza virus culture isolation and (4) influenza virus-specific IgG antibody levels in double serum samples from acute and convalescent patients; (3) in accordance with the diagnostic criteria of TCM syndrome of warm pathogen stagnation and Wei; (4) patients voluntarily received treatment and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) patients received influenza vaccination within 12 months before study initiation; (2) patients with severe influenza symptoms such as dyspnea and oxygen inhalation; (3) complicated with respiratory failure acute necrotizing encephalopathy septic shock multiple organ dysfunction and other critical illness; (4) patients with immunodeficiency such as AIDS receiving systemic steroids or other immunosuppressive agents; (5) patients took Chinese herbal medicine or antiviral drugs with similar efficacy to the experimental drugs; (6) pregnant or lactating women; (7) The patient was diagnosed with novel coronavirus pneumonia; (8) those who did not meet the inclusion criteria did not use the drugs as prescribed could not determine the efficacy or had incomplete data affecting the efficacy or safety evaluation; (9) participants who were enrolled in other clinical trials within 1 month before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to alleviation of influenza symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acetaminophen use;Relieve fever time;TCM syndrome score;Antigen negative conversion rate;EQ-5D-5L\CET\NOSE\FAI rating;Cellular inflammatory factors; | — |
Countries
China
Contacts
Public ContactZhang Wei
Department of Pulmonary Diseases Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed